Cenit AG header image

Cenit AG

CSH

Equity

ISIN DE0005407100 / Valor 889523

Xetra (2025-11-18)
EUR 6.83+1.15%

Cenit AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Cenit AG is a leading provider of digital solutions and software platforms, offering expertise in strategic partnerships with industry giants such as SAP, Dassault Systèmes, and IBM. The company's Digital Factory Solutions unit specializes in developing and implementing FASTSUITE, a 3D simulation platform for digital twins of production facilities, enabling manufacturing businesses to optimize their production systems. Additionally, the Digital Business Services unit offers sourcing and application management services to enhance clients' operational excellence in the product lifecycle management sphere. With a focus on innovation and efficiency in engineering and production processes, Cenit AG serves as a trusted consultant and integrator for businesses looking to optimize their digital production processes and succeed in their journey toward digital transformation.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (07.11.2025):

Cenit AG’s Q3 2025 financial results reveal a mixed performance amid a challenging economic environment. While the company recorded overall revenue growth for the first nine months of 2025, driven largely by its robust consulting and services segment, profitability was hit by increased operating expenses and one-time transformation costs. The highlights show that despite the revenue stability and enhanced liquidity, consolidated earnings, particularly operating income, faced significant downward pressure compared to the previous year.

Revenue Trends

For Q3 2025, Cenit AG’s revenue declined slightly (EUR 50,496k vs. EUR 52,078k in Q3 2024), although the nine‐month total increased by 1.8% (EUR 154,201k vs. EUR 151,433k). This modest overall improvement was driven primarily by a strong performance in consulting and services and the growing share of recurring sales in the proprietary software segment.

Profitability Impact

Despite stable revenue performance, the company experienced a decline in profitability. Consolidated EBIT for the nine months fell to a negative EUR 1,504k (a shift from EUR 3,966k in Q3 2024), resulting in a quarterly EBIT margin of -1.0% compared to 2.6% previously. The impact of one-time expenses and start-up losses from segment transformations contributed significantly to this downturn.

Liquidity and Cash Position

Cenit AG strengthened its liquidity position in Q3 2025 with cash and cash equivalents increasing by 24.1% to EUR 20,420k (as of September 30, 2025). Positive cash flow from current business activities (EUR 12,589k for nine months) and reduced investments supported a more robust balance sheet, despite the challenging operating environment.

Summarized from source with an LLMView Source

Key figures

-15.4%1Y
-50.7%3Y
-47.2%5Y

Performance

40.4%1Y
37.7%3Y
35.8%5Y

Volatility

Market cap

68 M

Market cap (USD)

Daily traded volume (Shares)

243

Daily traded volume (Shares)

1 day high/low

7.55 / 7.35

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Pegasystems Inc
Pegasystems Inc Pegasystems Inc Valor: 503997
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.87%USD 54.65
Halozyme Therapeutics Inc
Halozyme Therapeutics Inc Halozyme Therapeutics Inc Valor: 1814799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.76%USD 70.56
Tarsus Pharmaceuticals Inc
Tarsus Pharmaceuticals Inc Tarsus Pharmaceuticals Inc Valor: 57410241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.71%USD 74.17
Flywire Corp
Flywire Corp Flywire Corp Valor: 111444572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.51%USD 13.57
Sezzle Inc
Sezzle Inc Sezzle Inc Valor: 129105133
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 50.97
PAR Technology Corporation
PAR Technology Corporation PAR Technology Corporation Valor: 960461
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.66%USD 36.70
Toast Inc
Toast Inc Toast Inc Valor: 113470913
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.31%USD 34.71
Sportradar Group AG
Sportradar Group AG Sportradar Group AG Valor: 113423966
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.33%USD 21.81
Duolingo Inc
Duolingo Inc Duolingo Inc Valor: 112404331
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.67%USD 178.27
STEMMER IMAGING AG
STEMMER IMAGING AG STEMMER IMAGING AG Valor: 40430134
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 59.00